A detailed history of Wetherby Asset Management Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Wetherby Asset Management Inc holds 41,955 shares of RDY stock, worth $607,508. This represents 0.16% of its overall portfolio holdings.

Number of Shares
41,955
Previous 40,943 2.47%
Holding current value
$607,508
Previous $3.12 Million 6.86%
% of portfolio
0.16%
Previous 0.15%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$75.41 - $84.21 $76,314 - $85,220
1,012 Added 2.47%
41,955 $3.33 Million
Q2 2024

Aug 14, 2024

BUY
$68.26 - $76.19 $328,398 - $366,550
4,811 Added 13.32%
40,943 $3.12 Million
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $69,313 - $79,840
1,029 Added 2.93%
36,132 $2.65 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $46,981 - $51,096
731 Added 2.13%
35,103 $2.44 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $19,746 - $23,213
319 Added 0.94%
34,372 $2.3 Million
Q2 2023

Aug 14, 2023

SELL
$53.34 - $63.11 $23,682 - $28,020
-444 Reduced 1.29%
34,053 $2.15 Million
Q1 2023

May 12, 2023

BUY
$51.63 - $56.93 $367,347 - $405,056
7,115 Added 25.98%
34,497 $1.96 Million
Q4 2022

Feb 14, 2023

BUY
$51.15 - $57.45 $82,351 - $92,494
1,610 Added 6.25%
27,382 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $1,197 - $1,375
24 Added 0.09%
25,772 $1.35 Million
Q2 2022

Aug 15, 2022

BUY
$49.62 - $58.13 $303,327 - $355,348
6,113 Added 31.13%
25,748 $1.43 Million
Q1 2022

May 16, 2022

BUY
$48.27 - $65.25 $141,913 - $191,835
2,940 Added 17.61%
19,635 $1.09 Million
Q4 2021

Feb 14, 2022

BUY
$59.5 - $67.25 $2,558 - $2,891
43 Added 0.26%
16,695 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $4,333 - $5,420
72 Added 0.43%
16,652 $1.09 Million
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $12,237 - $14,617
197 Added 1.2%
16,580 $1.22 Million
Q1 2021

May 14, 2021

SELL
$57.98 - $73.08 $4,290 - $5,407
-74 Reduced 0.45%
16,383 $1.01 Million
Q4 2020

Feb 11, 2021

BUY
$62.61 - $71.29 $983,916 - $1.12 Million
15,715 Added 2117.92%
16,457 $1.17 Million
Q3 2020

Dec 16, 2020

SELL
$51.39 - $72.41 $778,250 - $1.1 Million
-15,144 Reduced 95.33%
742 $52,000
Q3 2020

Dec 16, 2020

SELL
$51.39 - $72.41 $44,246 - $62,345
-861 Reduced 5.14%
15,886 $1.11 Million
Q3 2020

Nov 13, 2020

SELL
$51.39 - $72.41 $35,613 - $50,180
-693 Reduced 3.97%
16,747 $1.17 Million
Q2 2020

Aug 14, 2020

SELL
$39.55 - $54.65 $27,012 - $37,325
-683 Reduced 3.77%
17,440 $924,000
Q1 2020

May 06, 2020

BUY
$34.75 - $45.85 $57,928 - $76,431
1,667 Added 10.13%
18,123 $731,000
Q4 2019

Jan 28, 2020

BUY
$36.66 - $41.78 $12,830 - $14,623
350 Added 2.17%
16,456 $668,000
Q3 2019

Oct 31, 2019

BUY
$34.82 - $39.26 $41,853 - $47,190
1,202 Added 8.06%
16,106 $610,000
Q2 2019

Jul 25, 2019

BUY
$36.05 - $42.76 $18,818 - $22,320
522 Added 3.63%
14,904 $559,000
Q1 2019

May 09, 2019

BUY
$35.77 - $40.57 $41,600 - $47,182
1,163 Added 8.8%
14,382 $583,000
Q4 2018

Jan 30, 2019

BUY
$31.89 - $38.44 $53,607 - $64,617
1,681 Added 14.57%
13,219 $499,000
Q3 2018

Nov 07, 2018

BUY
$29.25 - $36.73 $45,045 - $56,564
1,540 Added 15.4%
11,538 $399,000
Q2 2018

Jul 24, 2018

BUY
$28.49 - $35.06 $7,891 - $9,711
277 Added 2.85%
9,998 $322,000
Q1 2018

May 04, 2018

SELL
$31.93 - $39.54 $57,186 - $70,816
-1,791 Reduced 15.56%
9,721 $318,000
Q4 2017

Feb 09, 2018

BUY
$34.15 - $37.62 $38,350 - $42,247
1,123 Added 10.81%
11,512 $433,000
Q3 2017

Nov 13, 2017

BUY
$30.11 - $37.72 $312,812 - $391,873
10,389
10,389 $371,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.4B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.